RNA5SP406

Across TCGA pan-cancer cohorts, RNA5SP406 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNA5SP406 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNA5SP406 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP406 expression acts as an unfavorable survival marker.

LIHC and BLCA are the cancer types where RNA5SP406 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.195	0.777	.005	54	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNA5SP406–LIHC (OS)

Open the LIHC breakdown →